key: cord-0831487-8meshsj6
authors: Aly, Ashraf A.; Hassan, Alaa A.; Mohamed, Asmaa H.; Osman, Esraa M.; Bräse, Stefan; Nieger, Martin; Ibrahim, Mahmoud A. A.; Mostafa, Sara M.
title: Synthesis of 3,3′-methylenebis(4-hydroxyquinolin-2(1H)-ones) of prospective anti-COVID-19 drugs
date: 2020-09-14
journal: Mol Divers
DOI: 10.1007/s11030-020-10140-z
sha: 8a47a8470d74803fc2d3f1c521d9c36ee55daf88
doc_id: 831487
cord_uid: 8meshsj6

ABSTRACT: During formylation of 2-quinolones by DMF/Et(3)N mixture, the unexpected 3,3′-methylenebis(4-hydroxyquinolin-2(1H)-ones) were formed. The discussed mechanism was proved as due to the formation of 4-formyl-2-quinolone as intermediate. Reaction of the latter compound with the parent quinolone under the same reaction condition gave also the same product. The structure of the obtained products was elucidated via NMR, IR and mass spectra. X-ray structure analysis proved the anti-form of the obtained compounds, which were stabilized by the formation hydrogen bond. Molecular docking calculations showed that most of the synthesized compounds possessed good binding affinity to the SARS-CoV-2 main protease (M(pro)) in comparable to Darunavir. GRAPHIC ABSTRACT: [Image: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11030-020-10140-z) contains supplementary material, which is available to authorized users.

Dimethylformamide (DMF) can react as either an electrophilic and/or a nucleophilic agent. Therefore, DMF can be considered as the source of various key intermediates mediating a plethora of important reactions [1] . More significantly, DMF can participate in many reactions by serving as a multipurpose building block for various units, such as CH 3 , N(CH 3 ) 2 , HCO 2 , CHO, O, H − , H., (CH 3 ) 2 CO, etc. (Fig. 1) .

Alkyl-quinolones AQ analogs (Fig. 2 ) act synergistically to inhibit bacterial growth [2, 3] (i.e., two examples assigned as HHQ and HQNP).

Quinolones show a significant similarity to some anticancer [4] , anticonvulsant [5] [6] [7] , anti-dermatities [8] , antibacterial [9] , antimicrobial [10] , anti-Alzheimer [11] and pain relief [12] in addition to their medical, agricultural and industrial uses [13] [14] [15] . In previous work with quinolones, Aly et al., synthesized various classes of 2-quinolones such as 2′-amino-2,5′dioxo-5′,6′-dihydro-spiro(indoline-3,4′-pyrano [3,2-c] quinoline)-3′-carbonitriles [16] , 3-(methyl-thio)-4-oxo-4,5-dihydrofuro [3,2-c] quinolone-2-carbonitriles [17] , 3-(methylthio)-4-oxo-4,5-dihydro-furo [3,2-c] quinolone-2-carboxamides [17] , naphtho[2′,3′: 4, 5] furo [3,2-c] quinoline-6,7,12(5H)-trione derivatives (as ERK inhibitors with efficacy in BRAF-mutant Melanoma) [18] , 2,3-bis-(4-hydroxy-2-oxo-1,2-dihydroquinolin-3-yl)succinates, arylmethylene-bis-3,3′-quinoline-2-ones [19] , N-2,3-bis(6substituted-4-hydroxy-2-oxo-1,2-dihydroquinolin-3-yl) naphthalene-1,4-diones and substituted N-(methyl/ethyl) bisquinolinone triethylammonium salts [20] .

Han and Zhou [21] reported that the reaction of two equivalents of quinolone derivatives with one equivalent of aromatic aldehydes and potassium phtalamide under reflux at water-ethanol solution, gave the corresponding 3,3′-arylmethylene-bis(4-hydroxyquinolin-2(1H)-ones. Aly et al. [19] also reported another method of preparing arylmethylene-bis-3,3′-quinoline-2-ones via the reaction of equal equivalents of aromatic amines and diethyl malonate together with half equivalent of the corresponding aromatic aldehydes. 3,3′-Arylmethylene-bis(4-hydroxyquinolin-2(1H)-ones have a great biological activity especially in the composition of vitamin K [22, 23] and anticoagulation [24] . Choudhary et al. [25] synthesized some 3,3′-methylenebis(substituted-4-hydroxyquinolin-2(1H)-ones from the condensation between two molecules of quinolones and one molecule formaldehyde but also neither mechanism nor NMR spectra were discussed for the products. Previously, irradiation of only N-ethyl(methyl)-4-hydroxyquinol-2-ones, was tested in ethanol and afforded their corresponding 3,3′-methylenebis(substituted-4-hydroxyquinolin-2(1H)-ones, virtually eliminating the solvent as a source of formaldehyde [26] . The method suffered from low yields of the obtained products besides to its hazard condition. Moreover the stereochemistry of the obtained products was not discussed.

Utilizing by the expected formylation process during the reaction of 2-quinolones with dimethylformamide/triethylamine (DMF/Et 3 N) mixture [27, 28] , we explain the abnormal formation of 3,3′-methylenebis(4-hydroxyquinolin-2(1H)-ones). Also, the previous two aforementioned methods could not afford a general preparation method and suffered from low yields, hazardous conditions and no spectroscopic detailed data compared to our announced method of preparation.

Coronavirus disease (COVID-19) is a respiratory infectious disease caused by a novel virus strain, severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) [29] [30] [31] [32] . Molecular docking is utilized as a substantial tool in the drug discovery process to predict the binding mode and affinity of a drug candidate with a target. To combat COVID-19, the main protease of SARS-CoV-2 (M pro ) would be targeted due to its significant role in the viral replication process. Therefore, the binding modes and affinities of 3,3′-methylenebis(4-hydroxyquinolin-2(1H)-ones) as prospective SARS-CoV-2 inhibitors were predicted against M pro using Darunavir as a drug reference. Darunavir (Drug-Bank code: DB01264) is a human immunodeficiency virus (HIV) protease inhibitor and has been recently clinical investigated as anti-COVID-19 drug [33, 34] . The aforementioned encouraged us to synthesize various derivatives of 3,3′-methylenebis(4-hydroxyquinolin-2(1H)-ones) and established a general method of preparing the former compounds. In addition, we investigate the molecular docking of 3,3′-methylenebis(4-hydroxyquinolin-2(1H)-ones) as anti-COVID-19 using Darunavir as a prospective drug reference.

Upon addition of equimolar amounts of 4-hydroxy-2(1H)quinolones 1a-g and Et 3 N and gently heating in an oil path at 70-80 °C using DMF for 10-12 h, the resulting yellowish orange coloration of the solution was converted gradually to brown color and the 3,3′-methylenebis(substituted-4-hydroxyquinolin-2(1H)-ones 3a-g were precipitated in 70-87% yields (Scheme 1).

The structural assignment of all the obtained products 3a-g were based on IR, NMR ( 1 H NMR and 13 C NMR,) and mass spectra were performed; these and elemental analyses were in good agreement with the assigned structures. As an example, 3,3′-methylene-bis(1-ethyl-4-hydroxyquinolin-2(1H)-one (3g). The elemental analysis and mass spectrometry of compound 3g have the gross formula C 23 H 22 N 2 O 4 . The IR spectrum of 3g indicated the presence of OH at ν = 3500 (OH), 3030 (Ar-CH), 2867 (Alpihatic -CH) and 1643 cm −1 (C=O), whereas CH 2 group at ν = 1458 cm −1 . The 1 H NMR spectrum of 3g exhibited a triplet at δ H = 1.24 and a quartet at 4.38 ppm with the coupling constant J = 7.50 Hz arising from ethyl group. The 1 H NMR spectrum of 3g also showed the methylene protons at δ H = 3.89. Eight aromatic protons give rise to characteristic signals in the aromatic region of the spectrum, whereas the hydroxyl protons resonated at δ H = 12.65. The presence of methylene (CH 2 ) group is evident from 13 C-DEPT-NMR spectra; exhibiting positive signal at δ H = 12.95 ppm and negative signal at δ H = 37.59 ppm (CH 2 ). The 13 C NMR spectrum of 3g showed signals at δ C = 131.50, 122.67, 123.30 and 116.74 ppm due to Ar-CH (C-7), (CH-6), (CH-5) and (CH-8), respectively (Fig. 3) . The 13 C NMR spectrum of 3g supported the 13 C NMR spectroscopic data by the distinctive appearance of carbon signals representing quinolone C-4a and C-8a (Fig. 3 ) and resonated at δ C = 115.15 and 136.70 ppm, respectively. Also, the observed δ C values for carbon atoms in C-2 at δ C = 164.84, C-4 at 159.63 and C-3 at 108.53 ppm.

The structure of 3g was unambiguously determined by a single crystal structure determination showing the bismethylene system ( Fig. 4 and see CIF file, note that the crystallographic numbering does not correspond to the systematic IUPAC numbering rules). The bond lengths C(3)-C (21) and C (13) The anti-form of the formed compound is established and stabilized by the formed hydrogen bonding. On the basis of the previous reports [1, 27] , the formation of 3,3′-methylenebis(substituted-4-hydroxyquinolin-2(1H)ones 3a-g can be rationalized as depicted in Scheme 2. It would be proposed that Et 3 N would abstract a hydrogen proton from the active methylene in C-3 of 1a-g and therefore increasing the nucleophilicty of CH-3 of the quinolone Scheme 1 Formation of 3,3′-methylenebis(substituted-4-hydroxyquinolin-2(1H)-ones from the reaction of 4-hydroxy-2-quinolones 1a-g with DMF 2 and Et 3 N The reaction pathway was also supported via isolation of (CH 3 ) 2 NH, which was identified by TLC analysis.

Having established reaction conditions in hand, we investigated the formation 3a-g from the reaction of 3-formyl-4-hydroxy-2-quinolone derivatives 5a-g with 1a-g under the condition illustrated in Scheme 3. We reacted 5a-g with their resemble derivatives in 1a-g to obtain symmetric compounds like those in Scheme 1. Fortunately, the target symmetric products of 3,3′-methylenebis(substituted-4-hydroxyquinolin-2(1H)-ones) 3a-g were formed in 60-77% yields (Scheme 3).

Utilizing molecular docking technique, the binding modes and affinities of compounds 3a-g as prospective SARS-CoV-2 inhibitors were predicted against the main protease (M pro ). The geometrical structures of 3a-g were prepared and docked into the active site of SARS-CoV-2 M pro using AutoDock 4.2.6 software with docking parameters of GA= 250 and eval= 25,000,000. The predicted binding scores and features are summarized in Table 1 . The 2D representations of binding modes of the investigated compounds inside the active site of SARS-CoV-2 M pro are depicted in Fig. 5 .

What is interesting about the data in Table 1 is that compounds 3a-g demonstrated good binding affinities toward SARS-CoV-2 M pro with docking scores ranged from −8.63 to −7.05 kcal/mol. Besides, compounds 3a-g exhibited the same binding modes inside the active site of M pro , forming an essential hydrogen bond with key amino acid GLU166 residue (Fig. 5) . Further interactions including van der Waals, hydrophobic and pi-based interactions were also observed between the compound and the key amino acids inside the SARS-CoV-2 M pro active site (Fig. 5) .

Among the examined compounds, 3e showed the highest binding affinity with docking score of −8.6 kcal/mol against SARS-CoV-2 M pro . The high potentiality of 3e as SARS-CoV-2 M pro inhibitor would be returned to its capability to form four hydrogen bonds with THR190, GLN192, ARG188 and GLU166 amino acid with bond lengths of 2.10, 2.38, 1.79 and 2.08 Å, respectively (Figs. 5, 6).

The binding affinity and features of Darunavir were investigated and compared to compound 3e as SARS-CoV-2 M pro inhibitors. According to molecular docking calculations, Darunavir showed a good binding affinity of −8.19 kcal/mol, forming three hydrogen bonds with GLU166, and LEU167 with bond lengths of 1.94, 2.88 and 1.96 Å, respectively (Figs. 5, 6). A comparison of the molecular docking results revealed the competing binding affinity of 3e with regard to Darunavir as prospective SARS-CoV-2 M pro inhibitor.

Formylation of 2-quinolones by DMF/Et 3 N mixture caused an insertion of a methylene group between two symmetrically quninolones. DMF/Et 3 N mixture was proved as a formylatig agent of the parent 2-quinolones. Reaction of 4-formyl-2-quinolone with the parent 2-quinolone under the 

The proposed mechanism describes the formation of compounds 3a-g Scheme 3 Formation of compounds 3a-g from the reaction of 3-formyl-4-hydroxy-2-quinolones 5a-g with 1, 2 and Et 3 N same reaction condition gave the same product. The aforesaid 3-formyl-2-quinolones would prospectively be used to prepare various symm and/or asymm substitutents of the desired compounds. Molecular docking calculations demonstrated the competing binding affinity of 3e with regard to Darunavir as a prospective SARS-CoV-2 M pro inhibitor.

The IR spectra were recorded by ATR technique (ATR = Attenuated Total Reflection) with a FT device (FT-IR Bruker IFS 88), Institute of Organic Chemistry, Karlsruhe University, Karlsruhe, Germany. The NMR spectra were measured in DMSO-d 6 on a Bruker AV-400 spectrometer, 400 MHz for 1 

1,6-Disubstituted-quinoline-2,4-(1H,3H)-diones 1a-g were prepared according to the literature [35, 36] whereas carbaldehydes 5a, 5b, 5c-f and 5g were synthesized according to the literature [37] [38] [39] [40] .

Method a: A mixture of 1a-g (1 mmol), 15 ml of DMF (2), 0.100 g (1 mmol) Et 3 N was gently heated with stirring in an oil path at 70-80 °C for 10-12 h. The time period until the reactants had disappeared, as mentioned in Scheme 1, was monitored by TLC. The formed precipitate was then washed with ethanol (50 mL) and recrystallized from the stated solvents to give pure crystals of 3a-g. The filtrate was concentrated on vacuum and (CH 3 ) 2 NH was obtained and was identified by TLC analysis.

Method b: A a mixture of 1a-g (1 mmol), 5a-g (1 mmol) and 0.100 g (1 mmol) of Et 3 N in 2 15 ml of 2 was gently heated with stirring for 8-10 h in an oil path at 70-80 °C. Compounds 3a-g were obtained (i.e., Scheme 3) in pure state as above mentioned.

3,3′-Methylenebis(4-hydroxyquinolin-2(1H)-one) (3a). 3,3′-Methylenebis(7-chloro-4-hydroxyquinolin-2(1H)one) (3d) [25] . Orange crystals (DMF/CH 3 OH), yield (method a): 0.322 g (80%) or yield (method b): 0.274 g (68%); 1 for C 23 H 22 

The single-crystal X-ray diffraction study of 3g was carried out on a Bruker D8 Venture diffractometer with Photon II detector at 123(2) K using Cu-Kα radiation (λ = 1.54178 Å). Dual space/intrinsic methods (SHELXT) [41] were used for structure solution and refinement was carried out using SHELXL-2014 (full-matrix least-squares on F 2 ) [42] . Hydrogen atoms were localized by difference electron density determination and refined using a riding model (H(O) free). A semi-empirical absorption correction was applied.

3g: Orange crystals, C 23 

All molecular docking calculations were carried out using Autodock 4.2.6 software [43] . The crystal structure of SARS-CoV-2 main protease (M pro ; PDB code: 6LU7 [44] ) was taken as a template for all molecular docking calculations. Water molecules, ions and the ligand were deleted. The protonation state of M pro was evaluated using H ++ server, and all missing hydrogen atoms were added [45] . All docking parameters were kept to default values, except the number of genetic algorithm (GA) run and the maximum number of energy evaluation (eval) which were set to 250 and 25,000,000, respectively. The docking grid was set to 60 Å × 60 Å × 60 Å with a grid spacing value of 0.375 Å, and the grid center was placed at the center of the active site of M pro . The geometrical structures of all examined synthesized compounds were minimized with MMFF94s force field using SZYBKI software [46] and the partial atomic charges were assigned using Gasteiger method [47].

CCDC 2011538 (3g) contains the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_reque st/cif.

15 (s, 2H, NH), 12.86 ppm (s, 2H, OH); 13 C NMR (100 MHz, DMSO-d 6 ): δ = 20

Anal. Calcd. for C 19 H 12

14 (s, 2H, NH), 12.90 ppm (s, 2H, OH); 13 C NMR (100 MHz, DMSO-d 6 ): δ = 19

Anal. Calcd. for C 19 H 12 Br 2 N 2 O 4

Orange crystals (DMF/EtOH), yield (method a): 0.308 g (85%) or yield

IR (KBr): ν = 3450 (OH)

Ar-H), 12.87 ppm (s, 2H, OH); 13 C NMR (100 MHz, DMSO-d 6 ): δ = 19

m/z = 362 (M + , 33)

Orange crystals (DMF/EtOH), yield (method a): g 0.340 (87%) or yield

DMSO-d 6 ): δ = 1.24 (t, 6H, CH 3-), 3.89 (s, 2H, CH 2 ), 4.38 (q, 4H

m/z = 390 (M + , 18)

Dimethylformamide: much more than a solvent

Synergy and target promiscuity drive structural divergence in bacterial alkylquinolone biosynthesis

Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme

Potential anticancer activity of naturally occurring and semisynthetic derivatives of aculeatins A and B from Amomum aculeatum

Synthesis and anticonvulsant properties of new N-phenylamino derivatives of 2-azaspiro

Synthesis, physicochemical and anticonvulsant properties of new N-phenylamino derivatives of 2-azaspiro

Impact of aromatic substitution on the anticonvulsant activity of new N-(4-arylpiperazin-1-yl)-alkyl-2-azaspiro[4,5]decane-1,3-dione derivatives

Effect of TRK-820, a selective κ opioid receptor agonist, on scratching behavior in an animal model of atopic dermatitis

Synthesis and in vitro activity of novel 1β-methylcarbapenems having Spiro[2,4]heptanes moieties

]selenadiazole-4,1'-cyclohexane and spiro [chroman-2,1'-cyclohexan]-4-one-5-spiro-4-acetyl-2-(acetyl-amino)-∆2-1,3,4-thiadiazolines compounds

Preparation of spiro[azabicycloalkane-oxazolidinone] derivatives and analogs as α-7 nicotinic receptor agonists 066546

]dec-2-enes as vanilloid receptor 1 inhibi-tors122769

Decaspirones F − I, bioactive secondary metabolites from the saprophytic fungus Helicoma viridis

Synthesis, structure, spirocyclization mechanism, and glutathione peroxidase-like antioxidant activity of stable spirodiazaselenurane and spirodiazatellurane

Synthesis and antidepressant activities of some 3,5-diphenyl-2-pyrazolines

Synthesis of spiro(indoline-3,4'-pyrano[3,2-c]quinoline)-3'-carbonitriles

Formation of furo[3,2-c]quinolone-2-carbonitriles and 4-oxo-4,5-dihydrofuro[3,2-c]quinolone-2-carboxamides from reaction of quinoline-2,4-diones with 2-[bis(methylthio)-methylene] malononitrile

Design, synthesis and biological evaluation of fused naphthofuro[3,2-c]quinoline-6,7,12-triones and pyrano[3,2-c] quinolone-6,7,8,13-tetraones derivatives as ERK inhibitors with efficacy in BRAF-mutant melanoma

One-pot synthesis of 2,3-bis-(4-hydroxy-2-oxo-1,2-dihydroquinolin-3-yl)succinates and aryl methylene-bis-3,3'-quinoline-2-ones

Synthesis of novel 1,2-bis-quinolinyl-1,4-naphthoquinones: ERK2 inhibition, cytotoxicity and molecular docking studies

An efficient and green protocol for synthesis of 3,3'-arylmethylene-bis(4-hydroxyquinolin-2(1H)-ones) using potassium phthalimide as reusable Catalyst

Chemical studies of the antivitamin K series of compounds

Formation of a naphthalene derivative with hemorrhagic activity

Anticoagulant substances. VIII. Nitrogen analogs of dicoumarol and pelentan

Study of dimerization reactions of 4-hydroxycarbostyril/substituted 4-hydroxy carbostyril

The photoaddition of 4-hydroxycoumarin and N-methyl-4-hydroxyquinol-2-one to cyclohexene

Beckmann rearrangement of 2-hydroxy-5-methylacetophenone oxime using Vilsmeier-Haack reagent (POCl 3 /DMF): synthesis of some new heterocycles

Preparation of formate esters from O-TBDMS/O-TES protected alcohols. A one-step conversion using the Vilsmeier-Haack complex

Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment

Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals

In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel

Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan

Lack of antiviral activity of darunavir against SARS-CoV-2

Candidate drugs against SARS-CoV-2 and COVID-19

One pot synthesis of 7-[1,2-dihydro-4-hydroxy-1-methyl/phenyl-2-oxo-3-quinolinyl]-5,7-dihydro-5-methyl/phenyl-6H-[1]-benzo-pyrano

4-Hydroxy-3-nitro-2-quinolones and related compounds as inhibitors of allergic reactions

Synthesis of 4-hydroxy-3-formylideneamino-lH/methyl/phenylquinolin-2-ones

Synthesis of some multiazaheterocycles as substituents to quinolone moiety of specific biologicalactivity

Synthesis and colon anticancer activity of some novel thiazole/-2-quinolone derivatives

Synthesis of 3-amino-4,5-dihydro(5H)4-oxothieno[3,2-c]quinoline-2-carboxylic acids and their alkyl ester

SHELXT-integrated space-group and crystal-structure determination

Crystal structure refinement with SHELXL

AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility

Structure of M pro from COVID-19 virus and discovery of its inhibitors

++ : a server for estimating pKas and adding missing hydrogens to macromolecules

Iterative partial equalization of orbital electronegativity-a rapid access to atomic charges

Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations

The authors thank DFG Collaborative Center "3MET", Karlsruhe Institute of Technology, Karlsruhe, Germany for financial support to Prof Aly enabling him to carry out analyses in the aforesaid Institute. The computational work was completed with resources supported by the Science and Technology Development Fund, STDF, Egypt, Grants No. 5480 & 7972.Funding No funds were applicable.